Evidence map›Paper›PMID 40148564›Full record

ReviewNature microbiology2025

Characterizing extracellular vesicles of human fungal pathogens.

Marcio L Rodrigues, Guilhem Janbon, Richard J O'Connell, Thi-Thu-Huyen Chu, Robin C May, Hailing Jin, Flavia C G Reis, Lysangela R Alves, Rosana Puccia, Taicia P Fill and 12 more

Abstract readReview
In one paragraph

Review in Nature microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Antifungal turbinmicin alters functional vesicle cargo.Antimicrobial agents and chemotherapy · 2026
    Article
  3. International journal of molecular sciences · 2026
    Review
  4. Extracellular Vesicles fromPathogens (Basel, Switzerland) · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Extracellular vesicles ofInfection and immunity · 2026
    Article
  11. Caspofungin Reshapes the Extracellular Vesicles Metabolome ofJournal of fungi (Basel, Switzerland) · 2026
    Article
  12. Article
  13. Genetic Manipulation inJournal of fungi (Basel, Switzerland) · 2026
    Review
  14. Review
  15. Extracellular vesicles produced byExtracellular vesicles and circulating nucleic acids · 2026
    Review
  16. Selective DNA encapsulation in extracellular vesicles ofExtracellular vesicles and circulating nucleic acids · 2026
    Article
  17. Review
  18. Article
  19. 80 years of extracellular vesicles: from discovery to clinical translation.Extracellular vesicles and circulating nucleic acids · 2026
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Marcio L RodriguesInstituto Carlos Chagas, Fundação Oswaldo Cruz, Curitiba, Brazil. marcio.rodrigues@fiocruz.br.ORCID http://orcid.org/0000-0002-6081-3439
Guilhem JanbonRNA Biology of Fungal Pathogens Unit, Department of Mycology, Institut Pasteur, Université Paris Cité, Paris, France.ORCID http://orcid.org/0000-0002-4788-1154
Richard J O'ConnellBIOGER Research Unit, INRAE, Université Paris-Saclay, Paris, France.ORCID http://orcid.org/0000-0002-5358-6143
Thi-Thu-Huyen ChuBIOGER Research Unit, INRAE, Université Paris-Saclay, Paris, France.
Robin C MayInstitute of Microbiology and Infection and School of Biosciences, College of Life and Environmental Sciences, University of Birmingham, Birmingham, UK.ORCID http://orcid.org/0000-0001-5364-1838
Hailing JinDepartment of Microbiology and Plant Pathology, Center for Plant Cell Biology, Institute for Integrative Genome Biology, University of California, Riverside, Riverside, CA, USA.
Flavia C G ReisInstituto Carlos Chagas, Fundação Oswaldo Cruz, Curitiba, Brazil.
Lysangela R AlvesInstituto Carlos Chagas, Fundação Oswaldo Cruz, Curitiba, Brazil.ORCID http://orcid.org/0000-0002-1972-2658
Rosana PucciaDepartamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
Taicia P FillInstitute of Chemistry, State University of Campinas, São Paulo, Brazil.
Juliana RizzoCentro de Pesquisa em Medicina de Precisão, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0001-5538-6471
Daniel Zamith-MirandaDepartments of Medicine (Infectious Diseases) and Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0001-7532-2432
Kildare MirandaCentro de Pesquisa em Medicina de Precisão, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Teresa GonçalvesCenter for Neuroscience and Cell Biology and Center for Innovative Biomedicine and Biotechnology, Faculty of Medicine, University Coimbra, Coimbra, Portugal.
Iuliana V EneFungal Heterogeneity Group, Institut Pasteur, Université Paris Cité, Paris, France.ORCID http://orcid.org/0000-0002-0390-7084
Mehdi KabaniLaboratoire des Maladies Neurodégénératives, Université Paris-Saclay, CNRS and CEA, Paris, France.ORCID http://orcid.org/0000-0001-7440-6394
Marilyn AndersonDepartment of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0002-8257-5128
Neil A R GowMedical Research Council Centre for Medical Mycology, University of Exeter, Exeter, UK.ORCID http://orcid.org/0000-0002-2776-5850
David R AndesDepartment of Medicine, University of Wisconsin-Madison, Madison, WI, USA.ORCID http://orcid.org/0000-0002-7927-9950
Arturo CasadevallJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-9402-9167
Joshua D NosanchukDepartments of Medicine (Infectious Diseases) and Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0001-9905-5754
Leonardo NimrichterInstituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.ORCID http://orcid.org/0000-0001-9281-6856

Funding

Synergy of Host Defense Mechanisms in the LungR01HL059842 · NHLBI · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1997 to 2023
$7.4M
Biology of Fungal MelaninR01AI052733 · NIAID · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 2003 to 2019
$6.6M
Conjugate vaccines for prevention and treatment of cryptococcosis - COVID-19 Revision SupplementR01AI152078 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CASADEVALL, ARTURO · 2020 to 2024
$5.1M
The biology of Cryptococcus neoformans melanizationR01AI171093 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Arturo Casadevall, JOSHUA D NOSANCHUK · 2023 to 2026
$3.2M
Cross-kingdom RNA communications between plant and fungal pathogensR35GM136379 · NIGMS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI JIN, HAILING · 2020 to 2024
$2.1M
Candida auris extracellular vesicles subvert host immune responsesR21AI156104 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI NOSANCHUK, JOSHUA D · 2021 to 2022
$462k
An extracellular vesicle component as a candidate to control cryptococcosis.R01AI183314 · NIAID · FUNDACAO OSWALDO CRUZ · PI JOSHUA D NOSANCHUK, Marcio Lourenco Rodrigues · 2024 to 2026
$380k
Agence Nationale de la Recherche (French National Research Agency) ANR-17-CAPS-0004-01 and ANR-17-EUR-0007Agence Nationale de la Recherche (French National Research Agency) NAAgence Nationale de la Recherche (French National Research Agency) ResistEV AAPG2021 CE35; Project FEVCOM AAPG2023 CE35Centre National de la Recherche Scientifique (National Center for Scientific Research) NAFundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro) E-26/201.602/2022 and E-26/211.300/2021Fundação de Amparo à Pesquisa do Estado de São Paulo (São Paulo Research Foundation) 2022/02992-0Fundação de Amparo à Pesquisa do Estado de São Paulo (São Paulo Research Foundation) 2022/11123-5Institut Pasteur NAMinistry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Científico e Tecnológico (National Council for Scientific and Technological Development) 408843/2021-7 and 310778/2020-4National Science Foundation (NSF) IOS 2020731NHLBI NIH HHS R01 HL059842NIAID NIH HHS R01 AI052733NIAID NIH HHS R01 AI152078NIAID NIH HHS R01 AI171093NIAID NIH HHS R01 AI183314NIAID NIH HHS R21 AI156104NIGMS NIH HHS R35 GM136379RCUK | Medical Research Council (MRC) MR/M026663/2, MR/N006364/2Secretaria Regional do Mar, Ciência e Tecnologia (Regional Secretariat for the Sea, Science and Technology) UIDB/04539/2020, UIDP/04539/2020 and LA/P/0058/2020U.S. Department of Agriculture (United States Department of Agriculture) 2021-67013-34258U.S. Department of Health & Human Services | National Institutes of Health (NIH) AI052733-16, AI152078-01 and HL059842-19U.S. Department of Health & Human Services | National Institutes of Health (NIH) AI171093 and AI156104U.S. Department of Health & Human Services | National Institutes of Health (NIH) R35GM136379U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI183314Wellcome TrustWellcome Trust (Wellcome) 101873, 200208, 215599, 224323
6 · The paper itself

Abstract

Since their discovery in 2007, there has been growing awareness of the importance of fungal extracellular vesicles (EVs) for fungal physiology, host-pathogen interactions and virulence. Fungal EVs are nanostructures comprising bilayered membranes and molecules of various types that participate in several pathophysiological processes in fungal biology, including secretion, cellular communication, immunopathogenesis and drug resistance. However, many questions remain regarding the classification of EVs, their cellular origin, passage across the cell wall, experimental models for functional and compositional analyses, production in vitro and in vivo and biomarkers for EVs. Here, we discuss gaps in the literature of fungal EVs and identify key questions for the field. We present the history of fungal EV discovery, discuss five major unanswered questions in fungal EV biology and provide future perspectives for fungal EV research. We primarily focus our discussion on human fungal pathogens, but also extend it to include knowledge of other fungi, such as plant pathogens. With this Perspective we hope to stimulate new approaches and expand studies to understand the biology of fungal EVs.

Indexed as

Extracellular VesiclesFungiMycosesHost-Pathogen InteractionsHumansVirulence

Identifiers

PMID40148564
PMCPMC12035713

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.